Good morning, trader! We’re gearing up for another busy day of trading with the biggest pre-market stock movers for Thursday!
News moving stocks today include earnings reports, social media chatter, Omicron, and more.
Let’s get into that news below!
Pre-Market Stock Movers: 10 Top Gainers
- Digital World Acquisition (NASDAQ:DWAC) stock is soaring more than 21% .
- Phunware (NASDAQ:PHUN) shares are heading over 18% higher due to its possible connection to Digital World Acquisition.
- Abeona Therapeutics (NASDAQ:ABEO) stock is surging more than 16% .
- Arbutus Biopharma (NASDAQ:ABUS) shares are rising over 14% as it continues to rally on court ruling news.
- Snowflake (NYSE:SNOW) stock is sitting almost 14% higher .
- RLX Technology (NYSE:RLX) shares are climbing more than 12% .
- Remark (NASDAQ:MARK) stock is gaining over 11% despite a lack of news this morning.
- Express (NYSE:EXPR) shares are increasing nearly 11% .
- T2 Biosystems (NASDAQ:TTOO) stock is getting a more than 10% boost .
- Vir Biotechnology (NASDAQ:VIR) shares are up over 9% .
10 Top Losers
- Tantech (NASDAQ:TANH) stock is plummeting 42% .
- MDJM (NASDAQ:MDJH) shares are diving more than 16% on no apparent news today.
- 180 Life Sciences (NASDAQ:ATNF) stock is taking an over 13% beating .
- OceanPal (NASDAQ:OP) shares are pulling back more than 11% following a recent rally on their public debut.
- Clarus Therapeutics (NASDAQ:CRXT) stock is falling over 10%.
- Cumberland (NASDAQ:CPIX) shares are decreasing more than 9% .
- NLS Pharmaceutics (NASDAQ:NLSP) stock is slipping over 9% .
- Skylight Health Group (NASDAQ:SLHG) shares are dropping more than 9% .
- Pasithea Therapeutics (NASDAQ:KTTA) stock is dipping over 8% .
- Palatin Technologies (NYSEAMERICAN:PTN) shares close out our pre-market stock movers down more than 8% as they settle from a rally at the start of the week.
On the date of publication, William White did not have (either directly or indirectly) any positions in the securities mentioned in this article. The opinions expressed in this article are those of the writer, subject to the InvestorPlace.com Publishing Guidelines.